Archive: 05/12/2016

Double whammy for triple negative breast cancer

A promising new combination therapy for a particularly aggressive form of breast cancer has been identified by Weizmann Institute scientists, as was recently reported in Cancer Research. The potential dual-acting therapeutic ...

Dec 5, 2016

0

0

Filling need for fast and accurate assessment of blood's ability to clot

Case Western Reserve University researchers have developed a portable sensor that can assess the clotting ability of a person's blood 95 times faster than current methods—using only a single drop of blood.

Dec 5, 2016

0

1

Study shows improved response rates in myelodysplastic syndromes patients treated with lenalidomide and epoetin alpha

Patients with myelodysplastic syndromes (MDS) suffer from a reduction in the number of different types of blood cells, including red blood cells leading to the development of anemia. Many patients with lower-risk MDS benefit ...

Dec 5, 2016

Advocacy and community health care models complement research and clinical care

Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer. Their remarks come on the ...

Dec 5, 2016

0

0

CPX-351 improves survival following allogeneic hematopoietic cell transplant in acute myeloid leukemia patients

Acute myeloid leukemia, or AML, is a type of cancer of the blood and bone marrow. It occurs most often in older populations and progresses rapidly, interfering with the production of red blood cells, white blood cells and ...

Dec 5, 2016

Children with Down syndrome and ALL fare as well as others treated on DFCI ALL protocols

Despite an elevated risk of toxicity from chemotherapy, children with Down syndrome and acute lymphoblastic leukemia (ALL) did not experience higher rates of relapse or treatment-related mortality compared with other children ...

Dec 5, 2016